Return On Assets in % of NeuBase Therapeutics, Inc. from Q1 2012 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Return On Assets history and change rate from Q1 2012 to Q3 2023.
  • NeuBase Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2023 was -62 %, a 17.5% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2022 was -75 %, a 42.7% decline from 2021.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2021 was -53 %, a 31.2% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Return On Assets for 2020 was -77 %, a 83.9% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NeuBase Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -62 +13 +17.5% 01 Jul 2023 30 Sep 2023
Q2 2023 -76 -13 -20.7% 01 Apr 2023 30 Jun 2023
Q1 2023 -82 -26 -46.8% 01 Jan 2023 31 Mar 2023
Q4 2022 -82 -29 -55.1% 01 Oct 2022 31 Dec 2022
Q3 2022 -75 -23 -42.7% 01 Jul 2022 30 Sep 2022
Q2 2022 -63 -7 -11.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -55 -1 -1.2% 01 Jan 2022 31 Mar 2022
Q4 2021 -53 +8 +12.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -53 +24 +31.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -56 +138 +70.9% 01 Apr 2021 30 Jun 2021
Q1 2021 -55 +269 +83% 01 Jan 2021 31 Mar 2021
Q4 2020 -61 +308 +83.5% 01 Oct 2020 31 Dec 2020
Q3 2020 -77 +401 +83.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -194 +39 +16.6% 01 Apr 2020 30 Jun 2020
Q1 2020 -324 -238 -2.7% 01 Jan 2020 31 Mar 2020
Q4 2019 -369 -324 -7.2% 01 Oct 2019 31 Dec 2019
Q3 2019 -478 -467 -41.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -233 -179 -3.3% 01 Apr 2019 30 Jun 2019
Q1 2019 -86 -27 -46.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -45 +31 +40.6% 01 Oct 2018 31 Dec 2018
Q3 2018 -11 +70 +86.1% 28 Aug 2018 30 Sep 2018
Q2 2018 -54 +30 +35.8% 01 Apr 2018 30 Jun 2018
Q1 2018 -59 +38 +39.1% 01 Jan 2018 31 Mar 2018
Q4 2017 -75 +4 +5.5% 01 Oct 2017 31 Dec 2017
Q3 2017 -81 -11 -16.1% 01 Jul 2017 30 Sep 2017
Q2 2017 -85 -29 -51.2% 01 Apr 2017 30 Jun 2017
Q1 2017 -97 -56 -1.3% 01 Jan 2017 31 Mar 2017
Q4 2016 -80 -45 -1.3% 01 Oct 2016 31 Dec 2016
Q3 2016 -70 -36 -1% 01 Jul 2016 30 Sep 2016
Q2 2016 -56 -21 -58.6% 01 Apr 2016 30 Jun 2016
Q1 2016 -41 -7 -18.5% 01 Jan 2016 31 Mar 2016
Q4 2015 -35 +11 +23.7% 01 Oct 2015 31 Dec 2015
Q3 2015 -34 +13 +28% 01 Jul 2015 30 Sep 2015
Q2 2015 -35 +27 +43.4% 01 Apr 2015 30 Jun 2015
Q1 2015 -35 +98 +73.5% 01 Jan 2015 31 Mar 2015
Q4 2014 -46 +64 +58.2% 01 Oct 2014 31 Dec 2014
Q3 2014 -47 +77 +61.7% 01 Jul 2014 30 Sep 2014
Q2 2014 -62 +33 +34.2% 01 Apr 2014 30 Jun 2014
Q1 2014 -133 -33 -33.3% 01 Jan 2014 31 Mar 2014
Q4 2013 -110 +37 +24.9% 01 Oct 2013 31 Dec 2013
Q3 2013 -124 -67 -1.2% 01 Jul 2013 30 Sep 2013
Q2 2013 -95 +49 +33.9% 01 Apr 2013 30 Jun 2013
Q1 2013 -99 +215 +68.3% 01 Jan 2013 31 Mar 2013
Q4 2012 -146 01 Oct 2012 31 Dec 2012
Q3 2012 -57 01 Jul 2012 30 Sep 2012
Q2 2012 -143 01 Apr 2012 30 Jun 2012
Q1 2012 -314 01 Jan 2012 31 Mar 2012

NeuBase Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 -75 -23 -42.7% 01 Oct 2021 30 Sep 2022
2021 -53 +24 +31.2% 01 Oct 2020 30 Sep 2021
2020 -77 +401 +83.9% 01 Oct 2019 30 Sep 2020
2019 -478 -392 -4.5% 01 Oct 2018 30 Sep 2019
2018 -86 -5 -6.4% 01 Oct 2017 30 Sep 2018
2017 -81 -11 -16.1% 01 Oct 2016 30 Sep 2017
2016 -70 -36 -1% 01 Oct 2015 30 Sep 2016
2015 -34 +13 +28% 01 Oct 2014 30 Sep 2015
2014 -47 +77 +61.7% 01 Oct 2013 30 Sep 2014
2013 -124 -67 -1.2% 01 Oct 2012 30 Sep 2013
2012 -57 01 Oct 2011 30 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.